Legal & General Group
BIOR

Legal & General Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Legal & General Group’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7
Closed -$9K – 3719
2021
Q1 		$9K Buy
7
+5
+250% +$6.89K ﹤0.01% 3418
2020
Q4 		$2K Hold
2
– – ﹤0.01% 3476
2020
Q3 		$4K Buy
+2
New +$4.52K ﹤0.01% 3408

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's BIOR Position: Q2 2021 in Review

Legal & General Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2021, closing a stake of 7 shares — an estimated $9K sold.

Legal & General Group first reported a position in BIOR in Q3 2020 and held it in 3 quarters. The position peaked at $9K in Q1 2021. 42 funds tracked by Wall St. Rank hold BIOR as of Q2 2021.

  • Legal & General Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 7 Biora Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $9K.
  • Legal & General Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Legal & General Group's Biora Therapeutics, Inc. Common Stock position peaked at $9K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.